Clinical Research Study for Patients with Bullous Pemphigoid
Treatment options for bullous pemphigoid (BP) are limited. Patients who are 18 years of age or older, diagnosed with BP, and have symptoms such as itching and blisters, may be eligible to participate in the FJORD clinical trial. The FJORD study is being conducted to learn more about whether a study drug works to help improve symptoms of bullous pemphigoid.
The study drug has been approved in more than 50 countries for treating severe asthma. It is now being studied to see if it improves the symptoms of bullous pemphigoid. The study drug and study assessments will be provided at no cost. For more information about the FJORD Study and enrollment opportunities, please contact: 1-855-233-1701. Or check out the links for the FJORD Clinical Trial information and the FJORD Patient Brochure.
